| Literature DB >> 30524614 |
Şükrü Çolak1, Bünyamin Gürbulak1, Ekrem Çakar1, Hasan Bektaş1.
Abstract
INTRODUCTION: Endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) are commonly used for the minimally invasive treatment of submucosal lesions of the gastrointestinal tract. AIM: To evaluate the safety, efficacy, outcome and recurrence rate of EMR and ESD for mucosal and submucosal lesions in the colon and rectum.Entities:
Keywords: colorectal submucosal lesion; endoscopic mucosal resection; endoscopic submucosal dissection
Year: 2018 PMID: 30524614 PMCID: PMC6280075 DOI: 10.5114/wiitm.2018.78829
Source DB: PubMed Journal: Wideochir Inne Tech Maloinwazyjne ISSN: 1895-4588 Impact factor: 1.195
Location, age, gender, procedure and pathological diagnosis of lesions in patients who underwent EMR and ESD for colonic lesions
| Age/gender | Localization | Lesion size [cm] | Procedure | Pathology |
|---|---|---|---|---|
| 45/M | Transverse colon | 1.5 × 1.4 | EMR | Carcinoma |
| 52/M | Transverse colon | 1.5 × 0.9 | EMR | Villous adenoma |
| 40/M | Transverse colon | 1.2 × 0.9 | Polypectomy/EMR | Carcinoma |
| 63/M | Left colon | 2 × 0.9 | EMR | Carcinoma |
| 40/F | Sigmoid colon | 3 × 1.8 | Piecemeal EMR | Tubulo-villous adenoma-HGD |
| 70/M | Sigmoid colon | 3 × 1.1 | EMR | Carcinoma |
| 72/F | Sigmoid colon | 2 × 1.8 | EMR | Intramucosal carcinoma |
| 73/M | Sigmoid colon | 3 × 1.9 | EMR | Intramucosal carcinoma |
| 62/M | Sigmoid colon | 3 × 1.9 | Piecemeal EMR | Villous adenoma-HGD |
| 65/K | Rectosigmoid junction | 3 × 2.4 | EMR | Tubular adenoma |
| 70/M | Rectosigmoid junction | 1.5 × 1.2 | ESD | Tubular adenoma-LGD |
HGD – high grade dysplasia, LGD – low grade dysplasia.
Location, age, gender, procedure and pathological diagnosis of lesions in patients who underwent EMR and ESD for rectal lesions
| Age/gender | Localization | Lesion size [cm] | Procedure | Pathology |
|---|---|---|---|---|
| 80/M | Proximal rectum | 3 × 1.3 | ESD | Tubular adenoma |
| 42/F | Middle rectum | 1.2 × 0.8 | EMR | Neuroendocrine tumor |
| 59/M | Middle rectum | 1.5 × 0.4 | EMR | Tubular adenoma |
| 68/M | Middle rectum | 1.7 × 1.2 | ESD | Tubulo-villous adenoma with HGD |
| 77/M | Middle rectum | 1.8 × 0.5 | ESD | Invasive adenocarcinoma |
| 21/F | Middle rectum | 3 × 1.5 | EMR | Inflammatory polyp |
| 57/M | Distal rectum | 1 × 0.4 | EMR | Tubulo villous adenoma with |
| 63/M | Middle rectum | 3 × 1.7 | EMR | Intramucosal carcinoma |
| 36/M | Middle rectum | 1.2 × 0.7 | EMR | Neuroendocrine tumor |
| 65/M | Middle rectum | 4 × 1.9 | ESD | Carcinoma |
| 36/M | Middle rectum | 2 × 1.4 | ESD | Intramucosal carcinoma |
| 65/M | Middle rectum | 2 × 1.3 | Piecemeal EMR | Intramucosal carcinoma |
| 67/M | Middle rectum | 3 × 1.9 | Piecemeal EMR | Tubulo-villous adenoma |
| 47/M | Distal rectum | 2 × 1.3 | EMR | Tubular adenoma |
| 74/F | Distal rectum | 3 × 1.3 | Piecemeal EMR | Tubulo-villous adenoma with |
HGD – high grade dysplasia, LGD – low grade dysplasia.